![Julien Miara](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Julien Miara
Direttore/Membro del Consiglio presso
SENSORION
Profilo
Julien Miara is currently Director at Valerio Therapeutics SA since 2026, Independent Director at Sensorion SA, Director at Versity SA since 2023, and Principal at Invus SAS (Investment Management) since 2018.
Former positions include Director at TopoTarget UK Ltd. and President at Onxeo US.
Education includes a graduate degree from École des Hautes Études Commerciales du Nord, conferred in 2009.
Posizioni attive di Julien Miara
| Società | Posizione | Inizio |
|---|---|---|
| SENSORION | Direttore/Membro del Consiglio | - |
| VALERIO THERAPEUTICS | Direttore/Membro del Consiglio | - |
| VERSITY | Direttore/Membro del Consiglio | 11/11/2023 |
Invus SAS (Investment Management)
 Invus SAS (Investment Management) Investment ManagersFinance Invus-IM takes significant, long-term positions in public companies whose fundamentals and management they believe in. They focus on stocks that are trading below the firm's assessment of their intrinsic business value. The average holding period in their public equity portfolio is not measured in weeks or months but years. Leveraging their deep expertise in the healthcare sector, Invus-IM also works with their private equity team jointly investing in Series A and Series B rounds of private biotech companies making transformational bets on the future of healthcare, where they continue to support them as they go public. | Analyst-Equity | 01/01/2010 |
Precedenti posizioni note di Julien Miara
| Società | Posizione | Fine |
|---|---|---|
TopoTarget UK Ltd.
 TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Direttore/Membro del Consiglio | - |
Onxeo US | Presidente | - |
Formazione di Julien Miara
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
64
Relazioni di 1° grado
7
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Valerio Therapeutics SA
 Valerio Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops drugs for the treatment of cancer | Health Technology |
TopoTarget UK Ltd.
TopoTarget UK Ltd. Drugstore ChainsRetail Trade Develops anti-cancer drugs | Retail Trade |
Sensorion SA
 Sensorion SA Pharmaceuticals: MajorHealth Technology Operates as a research and development company that discovers drugs to treat inner ear disorders | Health Technology |
École des Hautes Études Commerciales du Nord
 École des Hautes Études Commerciales du Nord Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Invus SAS (Investment Management)
Invus SAS (Investment Management) Investment ManagersFinance Invus-IM takes significant, long-term positions in public companies whose fundamentals and management they believe in. They focus on stocks that are trading below the firm's assessment of their intrinsic business value. The average holding period in their public equity portfolio is not measured in weeks or months but years. Leveraging their deep expertise in the healthcare sector, Invus-IM also works with their private equity team jointly investing in Series A and Series B rounds of private biotech companies making transformational bets on the future of healthcare, where they continue to support them as they go public. | Finance |
Onxeo US | |
Versity SA
 Versity SA Real Estate DevelopmentFinance Operates an online real estate information platform | Finance |
